DIGITAL ANALYSIS OF NUCLEIC ACID MODIFICATION
In certain aspects, methods of the invention involve performing modification state specific enzymatic reaction of nucleic acid in a sample, determining a value associated with efficiency of the modification state specific enzymatic reaction based on a control, determining an amount of target nucleic acid in the sample, and normalizing the amount of target nucleic acid based on the efficiency value. Based on the normalized amount of target nucleic acid, the method further includes determining whether the normalized amount of target nucleic acid is indicative of a condition.
1 - 20 . (canceled)
21 . A method for analysis of nucleic acid, the method comprising:
obtaining a sample comprising (i) target nucleic acid comprising a locus and (ii) non-target nucleic acid comprising the locus, wherein the one of the (i) target nucleic acids and (ii) the non-target nucleic acid is methylated and the other is unmethylated;
treating a sample with a methylation-specific restriction enzyme (MSRE) to selectively digest only the non-target nucleic acid;
partitioning the sample into compartments;
performing amplification in the compartments with detectably-labeled probes specific to the locus; and
detecting signal from the probes to determine a quantity of the target nucleic acids that was present in the sample.
22 . The method of claim 21 , wherein the target nucleic acid comprises fetal nucleic acid and the sample comprises maternal blood or plasma.
23 . The method of claim 22 , wherein the target nucleic acid comprises maternal nucleic acid.
24 . The method of claim 21 , further comprising: measuring by digital PCR a quantity of a reference molecule in the sample that is not digested by the MSRE; and quantifying the target nucleic acid by comparison to the measured reference molecule.
25 . The method of claim 21 , further comprising adding into the sample a known quantity of a reference molecule that contains the locus and is not digested by the MSRE; measuring by digital PCR the reference molecule in the sample, and quantifying the target nucleic acid by comparison to the measured reference molecule.
26 . The method of claim 25 , wherein the target nucleic acid comprises fetal nucleic acid.
27 . The method of claim 21 , further comprising scoring the sample for a fetal aneuploidy.
28 . The method of claim 21 , wherein the detectably labeled probes comprise hydrolysis probes or molecular beacons.
29 . The method of claim 21 , wherein each of the detectably labeled probes is labeled with a fluorophore selected from the group consisting of: VIC, FAM, an Atto dye, a cyanine dye, ROX, Cy5, Cy5.5, malachite green, and Texas red.
30 . The method of claim 21 , further comprising reporting a condition in a subject based on the determined quantity of the nucleic acids in the first modification state in the sample.
31 . The method of claim 21 , further comprising performing the method with a known quantity of a control molecule that contains the locus and is not digested by the MSRE; measuring a quantity of the control molecule by digital PCR present after the treating step; and using the measured quantity of the control molecule to quantify completion of the selective digestion of the non-target nucleic acid.
32 . The method of claim 21 , wherein the compartments are aqueous droplets.
33 . The method of claim 32 , wherein each droplet is surrounded by an oil comprising a surfactant.
34 . The method of claim 21 , wherein the signal is detected using a detection apparatus comprising one selected from the group consisting of a microscope and a photomultiplier tube.
35 . The method of claim 34 , wherein a processor coupled to the detection apparatus determines the quantity of the target nucleic acids that was present in the sample
36 . The method of claim 35 , wherein the process determines a copy number for the locus in the target nucleic acid.
37 . The method of claim 22 , wherein the step are performed as a prenatal test for aneuploidy in a fetus.